Expression of interferon-γ by a coronavirus defective-interfering RNA vector and its effect on viral replication, spread, and pathogenicity

Virology

Volumn 233, Issue 2, 1997, Pages 327-338

  Zhang, Xuming ^a   Hinton, David R ^a   Cua, Daniel J ^a   Stohlman, Stephen A ^a   Lai, Michael M C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; MOLECULAR CLONING; MOUSE; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; VIRUS REPLICATION;

ANIMALIA; CORONAVIRUS; MURINAE; MURINE HEPATITIS VIRUS;

EID: 0030875194     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8598     Document Type: Article

References (54)

1. Benveniste, E. (1992). Inflammatory cytokines within the central nervous system: Sources, function, and mechanism of action. Am. J. Physiol. 263, 1-16.
2. Bianzani, F., and Autonelli, G. (1989). Physiological mechanisms of production and action of interferons in response to viral infections. Adv. Exp. Med. Biol. 257, 47-60.
3. Bukowski, J. F., Woda, B. A., Habu, S., Okumura, K., and Welsh, R. M. (1983). Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J. Immunol. 131, 1313-1331.
4. Carrigan, D. R., and Kehl-Knox, K. (1990). Identification of interferon-resistant subpopulations in several strains of measles virus: Positive selection by growth of the virus in brain tissue. J. Virol. 64, 1606-1615.
5. Cheever, L. S., Daniels, J. B., Pappenheimer, A. M., and Bailey, O. T. (1949). A murine virus (JHM) causing disseminated encephalomyelitis with extensive destruction of myelin. I. Isolation and biological properties of the virus. J. Exp. Med. 90, 181-194.
6. Cua, D. J., Hinton, D. R., and Stohlman, S. A. (1995). Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice: Th2-mediated suppression of autoimmune disease. J. Immunol. 155, 4052-4059.
7. Feducchi, E., Alonso, M. A., and Carrasco, L. (1989). Human gamma interferon and tumor necrosis factor exert a synergistic blockade on the replication of herpes simplex virus. J. Virol. 63, 1354-1359.
8. Fleming, J. Q., Stohlman, S. A., Harmon, R., Lai, M. M. C., Frelinger, J. A., and Weiner, L. P. (1983). Antigenic relationship of murine coronaviruses: Analysis using monoclonal antibodies to JHM (MHV-4) virus. Virology 131, 296-307.
9. Fleming, J. O., Trousdale, M. D., El-Zaatari, F., Stohlman, S. A., and Weiner, L. (1986). Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J. Virol. 58, 869-875.
10. Fleming, J. O., Trousdale, M. D., Bradbury, J., Stohlman, S. A., and Weiner, L. (1987). Experimental demyelination induced by coronavirus JHM (MHV-4): Molecular identification of a viral determinant of paralytic disease. Microb. Pathogen. 3, 9-20.
11. Gledhill, A. W., and Niven, J. S. F. (1955). Latent virus as exemplified by mouse hepatitis virus (MHV). Vet. Rev. Annotat. 1, 82-90.
12. Haller, O. (1981). Inborn resistance of mice to orthomyxoviruses. Curr. Top. Microbiol. Immunol. 92, 25-52.
13. Heise, M. T., and Virgin, IV, H. W. (1995). The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections. J. Virol. 69, 904-909.
14. Hirano, N., Fujiwara, K., Hino, S., and Matsumoto, M. (1974). Replication and plaque formation of mouse hepatitis virus (MHV-2) in mouse cell line DBT culture. Arch. Gesamte Virusforsch. 44, 298-302.
15. Ishida, T., Taguchi, F., Lee, Y.-S., Yamada, A., Tamura, T., and Fujiwara, K. (1978). Isolation of mouse hepatitis virus from infant mice with fatal diarrhea. Lab. Anim. Sci. 28, 269-276.
16. Ijzermans, J. N. M., and Marquet, R. L. (1989). Interferon-gamma: A review. Immunobiology 179, 456-473.
17. Kalvakolanu, D. V. R., Bandyopadhydy, S. K., Harter, M. L., and Sen, G. C. (1991). Inhibition of interferon-inducible gene expression by adenovirus E1A proteins: block in transcriptional complex formation. Proc. Natl. Acad. Sci. USA 88, 7459-7463.
18. Klavinskis, L. S., Geckeler, R., and Oldstone, M. B. A. (1989). Cytotoxic T lymphocyte control of acute lymphocytic choriomeningitis virus infection: interferon gamma, but not tumor necrosis factor alpha, displays antiviral activity in vivo. J. Gen. Virol. 70, 3317-3325.
19. Lai, M. M. C. (1992). RNA recombination in animal and plant viruses. Microbiol. Rev. 56, 61-79.
20. Lai, M. M. C., and Stohlman, S. A. (1992). Molecular basis of neuropathogenicity of mouse hepatitis virus. In "Molecular Neurovirology" (R. P. Roos, Ed.), pp. 319-348. Humana Press, Totowa, NJ.
21. Lane, T. E., Paoletti, A. D., and Buchmeier, M. J. (1997). Disassociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine coronavirus. J. Virol. 71, 2202-2210.
22. Lee, H.-J., Shieh, C.-K., Gorbalenya, A. E., Koonin, E. V., La Monica, N., Tuler, J., Bagdzyahdzhyan, A., and Lai, M. M. C. (1991). The complete sequence (22 kilobases) of murine coronavirus gene 1 encoding the putative proteases and RNA polymerase. Virology 180, 567-582.
23. Leist, T. P., Eppler, M., and Zinkernagel, R. M. (1989). Enhanced virus replication and inhibition of lymphocytic choriomeningitis virus disease in anti-gamma interferon-treated mice. J. Virol. 63, 2813-2819.
24. Lewis, J. A. (1982). The mechanism of action of interferon. In "Horizons in Biochemistry and Biophysics" (L. Kohn and R. Friedman, Eds.), p. 357. Wlley, New York.
25. Liao, C.-L., and Lai, M. M. C. (1994). Requirement of the 5′-end genomic sequence as an upstream cis-acting element for coronavirus subgenomic mRNA transcription. J. Virol. 68, 4727-4737.
26. Liao, C.-L., Zhang, X. M., and Lai, M. M. C. (1995). Coronavirus defective-interfering RNA as an expression vector: the generation of a pseudorecombinant mouse hepatitis virus expressing hemagglutinin-esterase. Virology 208, 319-327.
27. Lin, Y.-J., and Lai, M. M. C. (1993). Deletion mapping of a mouse hepatitis virus defective interfering RNA reveals the requirement of an internal and discontiguous sequence for replication. J. Virol. 67, 6110-6118.
28. Lucchiari, M., Martin, J., Modelell, M., and Pereira, C. A. (1991). Acquired immunity of A/Jmice to mouse hepatitis virus 3 infection: dependence on interferon-gamma synthesis and macrophage sensitivity to interferon-gamma. J. Gen. Virol. 72, 1317-1322.
29. Makino, S., Shieh, C.-K., Keck, J. G., and Lai, M. M. C. (1988a). Defective-interfering particles of murine coronavirus: Mechanism of synthesis of defective viral RNAs. Virology 163, 104-111.
30. Makino, S., Shieh, C.-K., Soe, L. H., Baker, S. C., and Lai, M. M. C. (1988b). Primary structure and translation of a defective-interfering RNA of murine coronavirus. Virology 166, 550-560.
31. Makino, S., Joo, M., and Makino, J. K. (1991). A system for study of coronavirus mRNA synthesis: A regulated, expressed subgenomic defective-interfering RNA results from intergenic site insertion. J. Virol. 65, 6031-6041.
32. Makino, S., and Joo, M. (1993). Effect of intergenic consensus sequence flanking sequences on coronavirus transcription. J. Virol. 67, 3304-3311.
33. Moskophidis, D., Battegay, M., Bruendler, M. A., Laine, E., Gresser, I., and Zinkernagel, R. M. (1994). Resistance of lymphocytic choriomeningitis virus to alpha/beta interferon and to gamma interferon. J. Virol. 68, 1951-1955.
34. Murphy, E., Hieny, S., Sher, A., and O'Garra, A. (1993). Detection of in vivo expression of interleukin-10 using a semi-quantitative polymerase chain reaction method in Schistosoma mansoni infected mice. J. Immunol. Methods 162, 211-223.
35. Okamura, H., Tsutsui, H., Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., Torigoe, K., Okura, T., Nukada, Y., Hattori, K., Akito, K., Namba, M., Tanabe, F., Konishi, K., Fukuda, S., and Kurimoto, M. (1995). Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 378, 88-91.
36. Pearce, B. D., Hobbs, M. V., McGraw, T. S., and Buchmeier, M. J. (1994). Cytokine induction during T-cell-mediated clearance of mouse hepatitis virus from neurons in vivo. J. Virol. 68, 5483-5495.
37. Perlman, S., and Ries, D. (1987). The astrocyte is a target cell in mice persistently infected with mouse hepatitis virus, strain JHM. Microb. Pathogen. 3, 309-314.
38. Pestka, S., and Langer, J. A. (1987). Interferons and their actions. Annu. Rev. Biochem. 56, 727-777.
39. Ramsey, A. J., Ruby, J., and Ramshaw, I. A. (1993). A case for cytokines as effector molecules in the resolution of virus infection. Immunol. Today 14, 155-157.
40. Ramshaw, I., Ruby, J., Ramsay, A., Ada, G., and Karupiah, G. (1992). Expression of cytokines by recombinant vaccinia viruses: A model for studying cytokines in virus infections in vivo. Immunol. Rev. 127, 157-182.
41. Rodriguez, M., Pavelko, K., and Coffman, R. L. (1995). Gamma interferon is critical for resistance to Theiler's virus-induced demyelination. J. Virol. 69, 7286-7290.
42. Smith, A. L., Barthold, S. W., De Souza, M. S., and Bottomly, K. (1991). The role of gamma interferon in infection of susceptible mice with murine coronavirus, MHV-JHM. Arch. Virol. 121, 89-100.
43. Stohlman, S. A., Brayton, P. R., Fleming, J. O., Weiner, L. P., and Lai, M. M. C. (1982). Isolation and characterization of two plaque morphology variants of the JHM neurotropic strain. J. Gen. Virol. 63, 265-275.
44. Stohlman, S. A., Bergmann, C. C., Van der Veen, R., and Hinton, D. R. (1995). Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system. J. Virol. 69, 684-694.
45. Su, Y.-H., Oakes, J. E., and Lausch, R. N. (1990). Ocular avirulence of a herpes simplex virus type I strain is associated with heightened sensitivity to alpha/beta interferon. J. Virol. 64, 2187-2192.
46. Trinchieri, G., and Perussia, B. (1985). Immune interferon: A pleiotropic lymphokine with multiple effects. Immunol. Today 6, 131-136.
47. Van der Most, R. G., Bredenbeek, P. J., and Spaan, W. J. M. (1991). A domain at the 3′-end of the polymerase gene is essential for encapsidation of coronavirus defective interfering RNAs. J. Virol. 65, 3219-3226.
48. Vassao, R. C., Sant-Anna, O. A., and Pereira, C. A. (1994a). A genetic analysis of macrophage activation and specific antibodies in relation to the resistance of heterogeneous mouse populations to MHV3 infection. Arch. Virol. 139, 417-425.
49. Vassao, R. Q., Mello, I. G., and Pereira, C. A. (1994b). Role of macrophages, interferon gamma and procoagulant activity in the resistance of genetic heterogeneous mouse populations to mouse hepatitis virus infection. Arch. Virol. 137, 277-288.
50. Wang, F.-I., Fleming, J. Q., and Lai, M. M. C. (1992). Sequence analysis of the spike protein gene of murine coronavirus variants: Study of genetic sites affecting neuropathogenicity. Virology 186, 742-749.
51. Wheelock, E. F. (1965). Interferon-like virus-inhibitor induced in human leukocytes by phytohemagglutinin. Science 149, 310-311.
52. Williams, R. K., Jang, G., and Holmes, K. V. (1991). Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins. Proc. Natl. Acad. Sci. USA 88, 5533-5536.
53. Wong, G. H. W., and Goeddel, D. V. (1986). Tumour necrosis factor α and β inhibit virus replication and synergize with interferons. Nature 323, 819-822.
54. Zhang, X. M., Liao, C.-L., and Lai, M. M. C. (1994). Coronavirus leader RNA regulates and initiates subgenomic mRNA transcription both in trans and in cis. J. Virol. 68, 4738-4746.